Faculty profile

Elie Haddad

ResearcherPediatricsUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Elie Haddad

Researcher

Pediatrics

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
56 publications in the last five years, latest in 2026.
Senior (last) author on 8 recent papers, a sign of leading a research group.
Principal investigator on 16 research grants (14 CIHR, 2 NSERC), most recently in 2023.
Supervisor on 2 trainee awards (2 CIHR), most recently in 2020.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

122

Publications

310

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Natural Killer Cells Cancer Immunotherapy Engineered Stem Cells Dendritic Cells Immunotherapy Car-Nk Cells Car-T Cells Solid Tumors

Latest papers

Functional stratification of MEFV variants by flow cytometric assessment of pyrin inflammasome activation.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC report.
Journal of human immunity · 2026 · senior author
IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients With Inborn Errors of Immunity From the Primary Immune Deficiency Treatment Consortium (PIDTC).
The journal of allergy and clinical immunology. In practice · 2026

All 122 publications

Latest funding

Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency
CIHR · 2024 · Co-investigator
$1,285,200
Canadian HIV Cure Enterprise 3.0: Targeting tissue HIV reservoirs
CIHR · 2024 · Co-investigator
$3,750,000
Epigenetic priming of neuroblastoma to Natural Killer cell-based immunotherapy
CIHR · 2023 · Principal investigator
$810,900

All 30 grants and awards

122 publications.

Functional stratification of MEFV variants by flow cytometric assessment of pyrin inflammasome activation.

Monjarret B, Fernandez I, Morin MP, Labrosse R, Samaan K, Barsalou J, Leveillé K, Martin C, Fabié A, Cros G, Haddad E, De Bruycker JJ, Touzot F

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2026

DOI: 10.1111/pai.70457 PMID: 42598795

Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC report.

Winestone LE, Logan BR, Liu X, Williams O, Dunn EA, Thakar MS, Kidd SA, Mousallem T, Dorsey MJ, O'Reilly RJ, Kapoor N, Forbes Satter L, Kapadia M, Jyonouchi SC, Chandra S, Ebens CL, Chellapandian D, Chaudhury S, Chen K, Dávila Saldaña BJ, Rayes A, Quigg TC, Chandrakasan S, Bednarski JJ, DeSantes KB, Teira P, Gillio AP, Eissa H, Knutsen AP, Aquino VM, Shereck EB, Moore TB, Caywood EH, Vander Lugt MT, Rozmus J, Broglie L, Yu LC, Shah AJ, Joshi AY, Buckley RH, Dara J, Oved JH, Abdel Azim H, Martinez CA, Prockop S, Sullivan KE, Bleesing JJ, Keller MD, Madden LM, Parikh S, Shenoy S, Seroogy CM, Rubin T, Licata J, Andolina JR, Kohn DB, Burroughs L, Leiding JW, Marsh RA, Notarangelo LD, Pai SY, Torgerson TR, Pulsipher MA, Heimall J, Cuvelier GDE, Griffith LM, Puck JM, Dvorak CC, Cowan MJ, Haddad E

Journal of human immunity2026Senior author

DOI: 10.70962/jhi.20250231 PMID: 42416786

IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients With Inborn Errors of Immunity From the Primary Immune Deficiency Treatment Consortium (PIDTC).

Arnold DE, Eissa H, Dunn E, Cuvelier GDE, Wright NAM, Marsh RA, Parikh S, Saldana BD, Vander Lugt MT, Bacchetta R, Satter LF, Chandrakasan S, Kellner E, Allenspach EJ, Schmitt EG, Logan B, Burroughs L, Cowan MJ, Griffith LM, Notarangelo L, Pai SY, Pulsipher MA, Dvorak CC, Haddad E, Puck JM, Torgerson TR, Leiding JW, Heimall J, Chan AY

The journal of allergy and clinical immunology. In practice2026

DOI: 10.1016/j.jaip.2026.05.025 PMID: 42242424

Kidney Transplant Outcomes in Coatomer Protein Complex Subunit Alpha (COPA) Syndrome: Report of Five Patients.

Triaille C, Côté K, Coulombe J, Daroux M, David C, Frémond ML, Haddad E, Khan N, Kokta V, Lapeyraque AL, Lebas C, Matoses Ruipérez ML, López Montesinos B, Reumaux H, Vogel TP, Morin MP, Phan V

American journal of kidney diseases : the official journal of the National Kidney Foundation2026

DOI: 10.1053/j.ajkd.2025.12.007 PMID: 41932423

Safety of multitargeted therapy using 2 biologics or 1 biologic and 1 JAKi in refractory paediatric inflammatory disorders: a retrospective multicentric cohort.

Triaille C, Jannone G, Boulanger C, De Bruycker JJ, De Somer L, Dehoorne J, Deslandres C, Dirks M, Groleau V, Grzywacz K, Haddad E, Halac U, Jantchou P, Kraus R, Labrosse R, Morin MP, Renson T, Scheers I, Touzot F, Chapuy L, Barsalou J

Annals of the rheumatic diseases2026

DOI: 10.1016/j.ard.2026.01.007 PMID: 41680028

TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMT.

Prunotto G, Parreillet M, Neven B, Moshous D, de Saint Basile G, Lindemans C, Leahy TR, Haddad E, Pichler H, Farela Neves J, Slatter M, Radwan N, Speckmann C, Tzivinikos C, Hoffenberg EJ, Ooi CY, Pinzon-Charry A, Ee LC, Ricci S, Albert MH, O'Donnell J, Worth A, Uhlig HH, Muise A, Lucchini G

Journal of human immunity2026

DOI: 10.70962/jhi.20250271 PMID: 42421851

Dominant-negative PSMB10 disrupts immunoproteasome assembly and leads to transient T lymphopenia.

Ghosh S, Wang Y, Schultheiss C, Borkhardt A, Dafun AS, Knipp L, Marwitz S, Ehl S, Soulard C, Haddad E, Dey D, Evans G, Golwala ZM, Bennstein SB, Laws HJ, Rohlfs M, Magg T, Binder M, Kreins AY, Bousquet MP, Marcoux J, Klein C, Conn GL, Meiners S, Hauck F

Journal of human immunity2026

DOI: 10.70962/jhi.20250129 PMID: 41971628

Prime Editing for p47phox-Deficient Chronic Granulomatous Disease.

Gori JL, Haddad E, Frangoul H, Kohn DB, Morris EC, Martin BN, Deary BA, Nickerson M, Scholz RL, Fernandez I, Leveille K, De Ravin SS, Kang EM, Pierzynski M, Estwick T, Littel P, Kuhns DB, Long Priel DA, Teira P, Turvey S, Arnold J, Evans MD, McManus M, Carpenter B, Waterman DP, Anzalone AV, Petrusich A, Osuna CE, O'Malley TT, Stewart-Ornstein J, Heath JM, Nehilla BJ, Asmal M, Malech HL

The New England journal of medicine2026

DOI: 10.1056/nejmoa2509807 PMID: 41358590

Modulating viscosity improves lentiviral transduction of NK cells: A simple solution to a persistent problem.

Bjelica M, Benyoucef A, Romero H, Beland K, Gagnon E, Haddad E

Molecular therapy. Advances2026Senior author

DOI: 10.1016/j.omta.2026.201692 PMID: 42137261

Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.

Alexander JL, Dávila Saldaña BJ, Brazauskas R, Dammalapati SG, Griffith LM, Shah AJ, Shimano KA, Ochs HD, Bleesing JJ, Ebens CL, Kapadia M, Bauchat A, Kapoor N, Oved JH, Eissa H, Lust H, Keller MD, Haines H, Chandrakasan S, Talano JA, Rayes A, Madden L, Shereck E, Miller HK, Satter LF, Martinez C, Rozmus J, Bednarski JJ, Yu LC, Chellapandian D, Aquino VM, Knutsen A, Chong H, Chopek A, Gillio AP, Joshi A, Rangarajan H, Moore TB, Andolina JR, DeSantes KB, Vander Lugt M, Prockop SE, Shyr DC, Sullivan KE, Parikh S, Weinacht KG, Torgerson TR, Marsh R, Dvorak CC, Chan AY, Haddad E, Heimall JR, Pulsipher MA, Leiding JW, Kohn DB, Puck JM, Notarangelo LD, Rawlings DJ, Cowan MJ, Petrovic A, Pai SY, Burroughs LM

Blood advances2026

DOI: 10.1182/bloodadvances.2025017662 PMID: 41346295

Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency

Co-investigatorCIHR2024Project Grant

Principal investigators: Ancuta, Petronela

Keywords: Antiretroviral Therapy; Aryl Hydrocarbon Receptor (Ahr); Confocal Microscopy/Imagestream; Crispr Cas9, Sirna; Flow Cytometry Analysis And Sorting; Hiv-1 Viral Reservoirs; Humanized Mice For Hiv Infection; Latency Reversing Agents; Pcr/Rt-Pcr, Western Blotting; Rna Sequencing, Massspec, Chip-Seq, Cut&Run, Atac-Seq

$1,285,200

Canadian HIV Cure Enterprise 3.0: Targeting tissue HIV reservoirs

Co-investigatorCIHR2024TG: Biomedical Res. for HIV/AIDS/STBBI-Next-Gen.Therapeutic Interv.-Large Team

Principal investigators: Chomont, Nicolas; Margolese, Shari L; Ancuta, Petronela; Angel, Jonathan B; Cohen, Eric A; Costiniuk, Cecilia T; Murooka, Thomas T

Keywords: Cd4 T Cells; Hiv Cure; Hiv Immunity; Hiv Persistence; Hiv Reservoir; Human Studies; Humanized Mouse Models; Myeloid Cells; Therapeutic Interventions; Tissue

$3,750,000

Epigenetic priming of neuroblastoma to Natural Killer cell-based immunotherapy

Principal investigatorCIHR2023Project Grant

Principal investigators: Raynal, Noël J; Haddad, Elie

Keywords: 3d Cell Culture; Epigenetics; Neuroblastoma; Nk Cells

$810,900

Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency

Co-investigatorCIHR2023Project Grant - Priority Announcement: Infection and Immunity

Principal investigators: Ancuta, Petronela

Keywords: Antiretroviral Therapy; Confocal Microscopy/Imagestream; Crispr Cas9; Flow Cytometry Analysis And Sorting; Hiv-1; Humanized Mice For Hiv Infection; Latency Reversing Agents; Pcr/Rt-Pcr; Rna Sequencing; Viral Reservoirs

$100,000

The interplay between Inborn Error of Immunity and blood disorders: unravelling immune defects behind common haematological diseases

Nominated PICIHR2023Team Grant: E-Rare Joint Transnational Call

Principal investigators: Haddad, Elie; Lavallée, Vincent-Philippe

Keywords: Autoimmunity; Blood Disorders; Genetics; Immune Dysregulation; Immunological Biomarkers; Inborn Error Of Immunity; Paediatric Immunology/Haematology

$450,000

Epigenetic priming of neuroblastoma to NK cell-based immunotherapy

Principal investigatorCIHR2022Project Grant - Priority Announcement: Pediatric Cancer Research

Principal investigators: Raynal, Noël J; Haddad, Elie

Keywords: Cancer Cells; Car Nk; Drug Screening; Epigenetics; Immunotherapy; Natural Killer Cells; Neuroblastoma; Pediatric Cancer; Preclinical Models Of Disease; Spheroids

$100,000

Empowering innovative hematopoietic stem cells (HSC)-based cancer immunotherapy through the creation of synthetic specific promoters

Nominated PICIHR2022Project Grant

Principal investigators: Haddad, Elie

Keywords: Breast Cancer; Cancer Immunotherapy; Car-Nk Cells; Car-T Cells; Chimeric Antigen Receptor (Car); Engineered Stem Cells; Hematopoietic Stem Cells; Solid Tumors; Synthetic Specific Promoters

$765,000

Platform of synthetic specific promoters for immunotherapies and regenerative medicine

Nominated PICIHR2021Project Grant - PA: Breast Cancer Research

Principal investigators: Haddad, Elie

Keywords: Cancer Immunotherapy; Car-Nk Cells; Car-T Cells; Chimeric Antigen Receptor; Engineered Stem Cells; Inducible Pluripotent Stem Cells; Regenerative Medicine; Solid Tumors; Synthetic Specific Promoters; Translational Aspect Of Gene Therapy

$100,000

New Modalities of Chimeric Antigen Receptor (CAR) Therapies in Pediatric Rhabdomyosarcoma

Nominated PICIHR2021Project Grant - Priority Announcement: Pediatric Cancer

Principal investigators: Haddad, Elie

Keywords: Cancer Immunotherapy; Car-Nk Cells; Car-T Cells; Chimeric Antigen Receptor; Engineered Stem Cells; Patient-Derived Xenograft; Rhabdomyosarcoma; Solid Tumors; Synthetic Specific Promoters; Translational Aspect Of Gene Therapy

$460,000

The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy

Co-investigatorCIHR2021Project Grant

Principal investigators: Ancuta, Petronela

Keywords: Antiretroviral Therapy; Chromatin Ip; Confocal Microscopy/Image Stream; Crispr Cas9; Flow Cytometry Sorting; Hiv-1; Humanized Mice; Rna Sequencing; Rorc2; Th17 Cells

$887,400

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Elie Haddad

Research

Latest papers

Latest funding

Functional stratification of MEFV variants by flow cytometric assessment of pyrin inflammasome activation.

Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC report.

IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients With Inborn Errors of Immunity From the Primary Immune Deficiency Treatment Consortium (PIDTC).

Kidney Transplant Outcomes in Coatomer Protein Complex Subunit Alpha (COPA) Syndrome: Report of Five Patients.

Safety of multitargeted therapy using 2 biologics or 1 biologic and 1 JAKi in refractory paediatric inflammatory disorders: a retrospective multicentric cohort.

TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMT.

Dominant-negative PSMB10 disrupts immunoproteasome assembly and leads to transient T lymphopenia.

Prime Editing for p47phox-Deficient Chronic Granulomatous Disease.

Modulating viscosity improves lentiviral transduction of NK cells: A simple solution to a persistent problem.

Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.

Frequent collaborators

Fabien Touzot

Michel Duval

Luis Murguia-Favela

Nathalie Arbour

Alexandre Prat

Jesse Papenburg

Jesse Papenburg

Nicola Wright

Catherine Larochelle

Manish Sadarangani

Daniel Sinnett

Pierre Duquette

Fatima Kakkar

Rae Yeung

Stuart Turvey

Heinrike Schmeling

Julia Orkin

Jaime Guzman

Olivier Drouin

Sonia Cellot

Matthew S Miller

Margaret Larche

Florina Moldovan

Lionel Carmant